Reheman Adili
- Hematology top 1%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Immunology top 10%
- Surgery top 10%
- Co-authors
- Heyu NiMichael HolinstatJohn FreedmanYiming WangPeter L. GrossChristopher M. SpringGuangheng ZhuOmolola Eniola‐Adefeso
- Topics
- Platelet Disorders and Treatments (26 papers)Antiplatelet Therapy and Cardiovascular Diseases (13 papers)Eicosanoids and Hypertension Pharmacology (8 papers)
- Journals
- Proceedings of the National Academy of SciencesCirculationJournal of Clinical Investigation
- Partner nations
- United StatesCanadaChina
In The Last Decade
Reheman Adili
60 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 118
- Hematology 897
- Molecular Biology 509
- Cardiology and Cardiovascular Medicine 453
- Immunology 417
- Surgery 295
Countries citing papers authored by Reheman Adili
This map shows the geographic impact of Reheman Adili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reheman Adili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reheman Adili more than expected).
Fields of papers citing papers by Reheman Adili
This network shows the impact of papers produced by Reheman Adili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reheman Adili. The network helps show where Reheman Adili may publish in the future.
Co-authorship network of co-authors of Reheman Adili
This figure shows the co-authorship network connecting the top 25 collaborators of Reheman Adili. A scholar is included among the top collaborators of Reheman Adili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reheman Adili. Reheman Adili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 11 | |
| 5 | 16 | |
| 6 | 10 | |
| 7 | 6 | |
| 8 | 66 | |
| 9 | 20 | |
| 10 | 27 | |
| 11 | 13 | |
| 12 | 80 | |
| 13 | 12 | |
| 14 | 146 | |
| 15 | 1 | |
| 16 | 76 | |
| 17 | 65 | |
| 18 | 51 | |
| 19 | 60 | |
| 20 | 80 |
About Reheman Adili
Reheman Adili is a scholar working on Hematology, Biochemistry and Internal Medicine, having authored 61 papers that have together received 2.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (26 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). The work is most often cited by research in Hematology (897 citations), Internal Medicine (159 citations) and Immunology and Allergy (201 citations). Reheman Adili has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Heyu Ni, Michael Holinstat, John Freedman, Yiming Wang, Peter L. Gross, Christopher M. Spring, Guangheng Zhu, Omolola Eniola‐Adefeso, Pingguo Chen and Margaret B. Fish. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.